Page last updated: 2024-08-17

medroxyprogesterone acetate and Pulmonary Consumption

medroxyprogesterone acetate has been researched along with Pulmonary Consumption in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davids, M; Dheda, K; Hapgood, JP; Meldau, R; Pooran, A; Semple, L; Smith, L; Theron, G; Tomasicchio, M1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Pulmonary Consumption

ArticleYear
The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.
    The Journal of infectious diseases, 2019, 04-08, Volume: 219, Issue:8

    Topics: Contraceptive Agents, Female; Dexamethasone; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immunity; Immunity, Cellular; Medroxyprogesterone Acetate; Mycobacterium tuberculosis; Norethindrone Acetate; Receptors, Glucocorticoid; T-Lymphocytes, Regulatory; Tuberculosis, Pulmonary

2019